Stately Bio - About the company
Stately Bio is a seed company based in Palo Alto (United States), founded in 2021. It operates as a Developer of machine learning cell imaging platform for regenerative medicines. Stately Bio has raised $12M in funding from AIX Ventures. The company has 227 active competitors, including 43 funded and 28 that have exited. Its top competitors include companies like Pandorum, Avita Medical and TreeFrog Therapeutics.
Company Details
Developer of machine learning cell imaging platform for regenerative medicines. The patented technology measures cell identity, behavior, and maturation directly from live-cell, label-free imaging. Using this technology, the company is pioneering stem cell-derived therapies. It partners with institutions and companies to advance cell therapy innovation.
Key Metrics
Founded Year
2021
Location
Palo Alto, United States
Stage
Seed
Total Funding
$12M in 1 round
Latest Funding Round
Investors
Ranked
82nd among 227 active competitors
Sign up to download Stately Bio's company profile
Stately Bio's funding and investors
Stately Bio has raised a total funding of $12M over 1 round. Its latest funding round was a Seed round on May 01, 2025 for $*****. 9 investors participated in its latest round. Stately Bio has 8 institutional investors and 3 angel investors.
Here is the list of recent funding rounds of Stately Bio:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 01, 2025 | 5097513 | Seed | 8846783 | 5712943 | 8409319 | 6104045 |
Access funding benchmarks and valuations. Sign up today!View details of Stately Bio's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Stately Bio's Competitors and alternates
Top competitors of Stately Bio include Pandorum, Avita Medical and TreeFrog Therapeutics. Here is the list of Top 10 competitors of Stately Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of regenerative medicine and 3D tissues | $52.1M | 65/100 | ||
2nd | Avita Medical 1992, Cambridge (United Kingdom), Public | Regenerative and Respiratory Medicine product company | - | 61/100 | |
3rd | TreeFrog Therapeutics 2018, Talence (France), Series B | Developer of stem cells and organoids using proprietary technology | $84.2M | 60/100 | |
4th |  Stellular Bio 2014, Watertown (United States), Series A | Developer of a platform for producing allogeneic, stem-cell-derived platelet-like cells | $37.5M | 59/100 | |
5th | Orthofix 1980, Lewisville (United States), Public | Developer of reconstructive and regenerative solutions for bone-related conditions | - | - | 59/100 |
6th | Developer of a microscopic system for the identification of proteins and biomarkers | $30M | 59/100 | ||
7th | Organogenesis 1985, Canton (United States), Public | Regenerative tissue innovations for advanced wound care and surgical solutions | $30M | 59/100 | |
8th |  Immunis 2018, Irvine (United States), Series A | Developer of cell therapies for age-related and disease-related immune deficits | $67.4M | 56/100 | |
9th | ROKIT Healthcare 2012, Seoul (South Korea), Public | Provider of 4D bio-printer solutions for tissue regenerative | $30M | 54/100 | |
10th |  Ensoma 2019, Boston (United States), Series B | Developer of in vivo hematopoietic stem cell engineering for genomic medicine | $205M | 54/100 | |
82nd |  Stately Bio 2021, Palo Alto (United States), Seed | Developer of machine learning cell imaging platform for regenerative medicines | $12M | 29/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Stately Bio's competitors? Click here to see the top ones
Stately Bio's Investments and acquisitions
Stately Bio has made no investments or acquisitions yet.
Reports related to Stately Bio
Here is the latest report on Stately Bio's geography:
News related to Stately Bio
•
Stately Bio’s $12 Million Seed Financing RoundGlobal Legal Chronicle•May 21, 2025•Stately Bio, Wilson Sonsini Goodrich & Rosati
•
Stately Bio Raises $12M in Seed FundingFinSMEs•May 01, 2025•Stately Bio, AIX Ventures, Dimension, Foothill Ventures and 5 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Stately Bio
Explore our recently published companies
